2017 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference - X4 Pharmaceuticals

2017 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference

2017 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference

October 2017

A Phase 1 Dose Finding Study of X4P-001 (An Oral CXCR4 Inhibitor) and Axitinib in Patients with Advanced Renal Cell Carcinoma

© Copyright 2024 X4 Pharmaceuticals. All Rights Reserved. Terms of Use | Privacy Policy | Consumer Health Data Privacy Policy